Industry › Clinical Trials
Press Releases
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report
Novotech Health Holdings Pte Ltd
Feb 09, 2022 15:00 HKT/SGT
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Avance Clinical
Jan 18, 2022 13:00 HKT/SGT
冠科美博 (Apollomics Inc.) 将于 2022 年 1 月 26-27 日（周三、周四）举办线上投资者活动
Apollomics, Inc.
Jan 12, 2022 09:27 HKT/SGT
冠科美博 (Apollomics Inc.) 將於 2022 年 1 月 26-27 日（週三、週四）舉辦線上投資者活動
Apollomics, Inc.
Jan 12, 2022 09:26 HKT/SGT
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022
Apollomics, Inc.
Jan 12, 2022 09:25 HKT/SGT
B-cell lymphoma clinical trials now open on the TrialWire Platform
TrialWire
Jan 05, 2022 17:10 HKT/SGT
冠科美博（Apollomics）首席执行官余国良博士当选为百华协会 (BayHelix Group) 董事会主席
Apollomics, Inc.
Jan 04, 2022 10:12 HKT/SGT
冠科美博（Apollomics）首席執行官余國良博士當選為百華協會 (BayHelix Group) 董事會主席
Apollomics, Inc.
Jan 04, 2022 10:11 HKT/SGT
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group
Apollomics, Inc.
Jan 04, 2022 10:10 HKT/SGT
Olympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World)
Olympus
Dec 02, 2021 14:00 HKT/SGT
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine
NEC Corporation
Nov 23, 2021 10:14 HKT/SGT
冠科美博（Apollomics）Uproleselan 注射液（APL-106）用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组
Apollomics, Inc.
Nov 22, 2021 10:42 HKT/SGT
冠科美博（Apollomics）Uproleselan 注射液（APL-106）用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組
Apollomics, Inc.
Nov 22, 2021 10:41 HKT/SGT